Fulminant hepatic failure treated with anti-endotoxin antibody.
Manthous
C A
CA
Department of Medicine, University of Chicago Medical School, IL.
Schmidt
G A
GA
Kemp
R
R
Wood
L D
LD
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D006439:Hemodynamics / Q000187:drug effects; D006501:Hepatic Encephalopathy / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C068069:nebacumab